Successful endovascular treatment in patients with acute thromboembolic ischemia of the lower limb including the crural arteries

Table 1 Baseline characteristics of our seven patients

	Patient A	Patient B	Patient C	Patient D	Patient E	Patient F	Patient G	All patients
Sex	Male	Male	Male	Male	Male	Male	Male	All male (100%)
Age (yr)	89	72	55	67	85	67	80	74 ± 11
Cardiovascular risk factors	Hypertension	Hypertension	Hypertension	Hypertension	Hypertension	Hypertension	Hypertension	Hypertension (100%)
	Hyperlipidemia	Hyperlipidemia	Hyperlipidemia	Hyperlipidemia	Hyperlipidemia	Hyperlipidemia	Hyperlipidemia	Hyperlipidemia (100%)
	Type 2 DM	Type 2 DM	Type 2 DM	Smoking	Type 2 DM	Smoking		Type 2 DM (57%)
			Smoking					Smoking (43%)
PAD history	No	Surgical endatherectomy of the left common femoral artery 2012	No	Prior Angioplasty and stent placement in the left popliteal artery 2015	No	Prior Angioplasty and stent placement in the left popliteal artery 2016	No	3/7 (43%)
LV function	Moderately reduced	Normal	Normal	Normal	Severely reduced	Mildly reduced	Normal	Reduced in 3/7 (43%)
Symptoms onset	For 12 h	For 16 h	For 2 h	For 12 h	For 36 h	For 6 h	For 36 h	17 ± 13
CAD history	3 vessel CAD	3 vessel CAD	No	3 vessel CAD	3 vessel CAD	3 vessel CAD	3 vessel CAD	6/7 (86%)
						GABG 2005
Baseline medication	Aspirin	Aspirin	Aspirin	Aspirin	Aspirin	Aspirin	Aspirin	Aspirin (100%)
	ß-blocker	ß-blocker	ACE inhibitor	ß-blocker	ß-blocker	ß-blocker	ß-blocker	ß-blocker (86%)
	ACE inhibitor	ACE inhibitor	Statin	ACE inhibitor	ACE inhibitor	ACE inhibitor	ACE inhibitor	ACE inhibitor 100%)
	Statin	Statin		Statin	Statin	Statin	Statin	Statin (100%)
	Diuretics			Diuretics	Diuretics	Diuretics		Diuretics (57%)
Other comorbidities	Reduced renal function with estimated GFR of -40 mL/min/1.73 m²	Reduced renal function with estimated GFR of -50 mL/min/1.73 m²	None	Reduced renal function with estimated GFR of -45 mL/min/1.73 m²	Reduced renal function with estimated GFR of -55 mL/min/1.73 m²	Reduced renal function with estimated GFR of -50 mL/min/1.73 m²	Reduced renal function with estimated GFR of -40 mL/min/1.73 m²	Reduced renal function (86%)
	Atrial fibrillation	Atrial fibrillation		Atrial fibrillation	Atrial fibrillation		Atrial fibrillation	Atrial fibrillation (71%)
	Heart failure				Heart failure NYHA III		Heart failure NYHA II	Heart failure (43%)
	NYHA III

ACE: Angiotensin converting enzyme; LV: Left ventricular; CAD: Coronary artery Disease; PAD: Peripheral artery disease; NYHA: New York Heart Association; GFR: Glomerular filtration rate.